← Eichor
Study identifier: NCT04007783 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Validation of the O-bridge Protocol: a Prospective, Multicenter Trial

Condition: Benign or Malignant Tumour of the Oral Cavity · Stage III-IV Osteonecrosis · Mandibular Reconstruction  ·  Sponsor: AZ Sint-Jan AV

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Surgical reconstruction to restore oral function and aesthetics after major ablative surgery in the oral cavity forms a challenge to maxillofacial surgeons, and greatly impacts patient' quality of life (QOL). The "Oncological-bridge (O-bridge®)" protocol, which offers (immediate/delayed) fixed prosthetic rehabilitation in a minimum of sessions and a strongly reduced two-week treatment time.

This description comes directly from the study's public registry record.

Talk to the study team

Araceli Diez-Fraile, PhD  ·  0032(0)50459660  ·  araceli.diez-fraile@azsintjan.be

Always discuss trial participation with your own doctor first.

Locations (5)

Ziekenhuis Netwerk AntwerpenAntwerp, BelgiumRecruiting
ZMACK association - Antwerp University HospitalAntwerp, BelgiumRecruiting
Division of Oral and Maxillofacial Surgery, Department of Surgery, AZ Sint-Jan Brugge-Oostende AVBruges, BelgiumRecruiting
University Hospital LeuvenLeuven, BelgiumRecruiting
AZ NikolaasSint-Niklaas, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04007783